Humana Inc. (NYSE:HUM – Free Report) – Equities researchers at Zacks Research cut their Q3 2026 earnings per share estimates for shares of Humana in a report released on Wednesday, August 12th. Zacks Research analyst Team now forecasts that the insurance provider will earn ($1.18) per share for the quarter, down from their prior estimate of $0.08. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Humana’s current full-year earnings is $9.09 per share. Zacks Research also issued estimates for Humana’s Q4 2026 earnings at ($7.74) EPS, FY2026 earnings at $9.00 EPS, Q2 2027 earnings at $5.27 EPS, Q3 2027 earnings at ($1.23) EPS, Q4 2027 earnings at ($2.10) EPS, FY2027 earnings at $10.98 EPS, Q1 2028 earnings at $11.53 EPS, Q2 2028 earnings at $6.74 EPS and FY2028 earnings at $30.30 EPS.
Humana (NYSE:HUM – Get Free Report) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter last year, the business posted $6.27 earnings per share. The firm’s revenue was up 26.2% on a year-over-year basis.
Get Our Latest Stock Analysis on HUM
Humana Stock Performance
Shares of NYSE HUM opened at $384.50 on Friday. The firm’s fifty day moving average is $381.25 and its two-hundred day moving average is $274.88. Humana has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market cap of $46.17 billion, a P/E ratio of 36.38, a P/E/G ratio of 2.22 and a beta of 0.72.
Hedge Funds Weigh In On Humana
A number of institutional investors have recently modified their holdings of HUM. Vanguard Group Inc. grew its holdings in shares of Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after buying an additional 106,030 shares during the last quarter. BlackRock Inc. purchased a new position in Humana in the 2nd quarter valued at $4,138,160,000. Capital International Investors increased its stake in Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after buying an additional 3,097,571 shares during the period. Pzena Investment Management LLC raised its position in Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after buying an additional 1,398,774 shares during the last quarter. Finally, State Street Corp increased its stake in shares of Humana by 1.8% during the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after acquiring an additional 97,211 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.
Humana News Roundup
Here are the key news stories impacting Humana this week:
- Positive Sentiment: Wall Street analysts are moderately optimistic about Humana’s prospects after the stock outperformed the broader market over the past year, providing a supportive backdrop for investor sentiment. Do Wall Street Analysts Like Humana Stock?
- Positive Sentiment: Zacks Research raised its first-quarter 2027 earnings-per-share forecast to $9.04 from $8.70. The increase suggests improved expectations for Humana’s near-term operating performance, despite the firm retaining a Hold rating. Humana earnings estimate update
- Positive Sentiment: Humana is partnering with Cityblock Health to support low-income and dual-eligible Medicare Advantage members. The initiative could strengthen care coordination and outcomes in an important, higher-need segment. Humana teams with Cityblock
- Positive Sentiment: A HealthStream agreement will fund 1,000 caregiver scholarships and provide recruitment and retention tools in Indiana, potentially helping Humana address staffing needs at its CenterWell and care-delivery operations. Humana HealthStream deal
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Stories
- Five stocks we like better than Humana
- Inside Teledyne’s Bold Bet on the Future of Medical Imaging
- Why Are Analysts Freaking Out About Apple’s All-Glass iPhone?
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
